Home / Daily News / Stock Growth in Focus For Bio-Rad Laboratories, Inc. (NYSE:BIO) as Analysts Estimate 20.56% Growth


Research brokerages are projecting Bio-Rad Laboratories, Inc. (NYSE:BIO) to grow at an accelerated rate over the next 5 years.  Wall Street analysts are looking for the company to grow 20.56% over the next year and 19.60% over the next five years.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Every investor strives to maximize returns in the stock market. To achieve success in the market, investors may take many different paths. Because there are so many different strategies, one investor’s road may end up being quite different than another. Over time, the investor may have to overcome various difficulties. Trading the stock market can indeed be exhilarating, but it can also cause lots of strife. Some investors may be able to be much more aggressive when creating the stock portfolio. Others may have a much lower risk threshold and choose to play it a bit safer. Because humans are prone to error, there may be many mistakes made along the way. Investors who are able to identify mistakes and learn from them may find themselves in a much better position down the road.

Bio-Rad Laboratories, Inc. (NYSE:BIO)’s trailing 12- months EPS is 10.55.  Last year, their EPS growth was 502.10% and their EPS growth over the past five years was 31.20%.  


Let’s start off by taking a look at how the stock has been performing recently.  Over the past twelve months, Bio-Rad Laboratories, Inc. (NYSE:BIO)’s stock was 60.06%.  Last week, it was 2.62%, 11.50% over the last quarter, and  27.37% for the past half-year. 

Over the past 50 days, Bio-Rad Laboratories, Inc. stock was -1.35% off of the high and 15.75% removed from the low.  Their 52-Week High and Low are noted here.  -1.35% (High), 67.93%, (Low). 


Bio-Rad Laboratories, Inc. (NYSE:BIO)’s performance this year to date is 60.06%.  The stock has performed 2.62% over the last seven days, 12.08% over the last thirty, and 11.50% over the last three months.  Over the last six months, Bio-Rad Laboratories, Inc.’s stock has been 27.37% and 35.00% for the year.


Wall Street analysts are have a consensus analyst recommendation of 1.50 on the stock.  This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  Brokerages covering the name have a $390.00 on the stock.

Investors are constantly hunting for bargains when picking stocks. There may be times when a particular stock might be flying under the radar, but is usually only a matter of time before someone catches on. Investors might be widening their stock focus to find these undervalued names. This may include small caps, foreign stocks, or stocks that just haven’t become household names. Expanding the scope of interest may help the investor discover areas of future opportunity. Although there are plenty of investors who will stick to the solid, historically steady stocks, there are plenty more that are searching for that next big winner that will give the portfolio a big bump.

The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs.  Where quoted, past performance is not indicative of future performance.

Share this page